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Background: Dynamic in-shoe plantar pressure assessment is used both in research and clinical practice to
evaluate therapeutic footwear interventions in neuropathic diabetic patients. The aim was to determine the
required number of footsteps for reliable and valid in-shoe plantar pressure data in these patients.
Methods: In 30 neuropathic diabetic patients wearing custom-made therapeutic footwear, in-shoe plantar
pressures were measured for a minimum of 20 midgait walking steps per foot. For each incremental number
of steps and for each of six anatomical regions per foot, peak pressure, pressure–time integral, contact area,
contact time, and force–time integral were calculated. Reliability was assessed by calculating intraclass
correlation coefﬁcients. Validity was assessed by calculating the coefﬁcient of variation between each n-step
protocol and the 20-step reference protocol based on Limits of Agreement analysis. Data was considered
reliable with intraclass correlation coefﬁcients N0.90 and valid with coefﬁcients of variation b10%.
Findings: Three stepsper footwere required toobtain reliabledata for each foot regionandparameter.Dependingon
the parameter, between 7 and 17 steps per foot were required to obtain valid data. With the exception of deviant
outcomes in three forefoot regions for force–time integral, overall 12 steps per foot were required for valid data.
Interpretation: For neuropathic diabetic patients wearing custom-made therapeutic footwear, 12 midgait steps per
foot are required to obtain valid and reliable in-shoe plantar pressure data. This provides directions for the use of in-
shoe plantar pressure analysis in research and clinical practice in this patient group.
© 2011 Elsevier Ltd. Open access under the Elsevier OA license. 1. Introduction
In-shoe dynamic plantar foot pressure assessment is used more and
more in research and clinical practice to evaluate the efﬁcacy of
therapeutic footwear prescriptions in diabetic patients with peripheral
neuropathy. Elevated plantar foot pressure is a causative factor of foot
ulceration in these patients (Frykberg et al. 1998; Phamet al. 2000), and
foot ulceration is an important precursor of infection and amputation
(Boulton et al. 2004). To reduce the risk of ulceration, therapeutic
footwear is commonly prescribed. This footwear primarily acts to
redistribute plantar pressures on the foot and relieve pressure in regions
at risk for ulceration (Bus et al. 2008; Paton et al. 2011). To adequately
assess the efﬁcacy of therapeutic footwear interventions, one has to rely
on representative and reliable in-shoe plantar pressure data.
To obtain such a representative (i.e. valid) and reliable estimate of
the true in-shoe plantar pressures, data from multiple footsteps are
generally collected, often in multiple walking trials. However, the
precise number of collected steps per foot is often not reported andmay
vary considerably, from as few as three steps (Garrow et al. 2005) to as
many as 30–40 steps (Owings et al. 2008). Too few collected footstepser, University of Amsterdam,
Amsterdam, The Netherlands.
evier OA license. maycompromisedata quality. Toomanycollected footstepsmay fatigue
patients, in particular with repeated measurements or multiple
conditions tested and will increase data collection and analysis time.
Guidelines for the required number of footsteps for valid and reliable in-
shoe plantar pressure data in neuropathic diabetic patients currently do
not exist.
The only study we found on this topic assessed healthy subjects
and found that 8 steps per foot were required to obtain reliable in-
shoe plantar pressure data (Kernozek et al. 1996). However, this study
assessed only data reliability, not data validity, assessments were at
the group level, and subjects were tested in standard footwear on a
treadmill at controlled speeds. This limits the extrapolation of these
ﬁndings to individual diabetic patients of which many have
abnormalities in foot structure, gait, or balance (Ducic et al. 2004;
Katoulis et al. 1997; Veves et al. 1992), andwho are generally tested in
a clinical setting wearing therapeutic footwear and walking over-
ground at comfortable speeds.
The above considerations suggest that speciﬁc guidelines for the
requirednumberof footsteps for valid and reliable in-shoepressure data
in neuropathic diabetic patients are needed to help direct clinical
practice and research toward proper use of in-shoe plantar pressure
analysis. Therefore, the aim of this study was to determine the number
of footsteps required to obtain valid and reliable in-shoe plantar
pressure data in neuropathic diabetic patients wearing custom-made
881M.L.J. Arts, S.A. Bus / Clinical Biomechanics 26 (2011) 880–884footwear. For this analysis, we focused on themost commonly reported
pressure parameters in diabetic footwear studies.
2. Methods
2.1. Subjects
Thirty neuropathic diabetic patients (22 males, 8 females, mean
(SD) age 58.5 (10.9) years, mean body mass index (BMI) 31.5 (7.5))
who were at risk for plantar foot ulceration participated in the study.
Mean time since diabetes onset was 25.2(16.9)years. Twelve patients
had diabetes type I, 18 patients had diabetes type 2. All patients had
peripheral neuropathy, indicated by a loss of protective sensation in
the foot through the inability to sense the 10 g Semmes–Weinstein
monoﬁlament at 3 plantar foot sites tested (hallux, ﬁrst metatarsal
head, and ﬁfth metatarsal head) (Apelqvist et al. 2008). Each patient
presented with one or more foot deformities which were assessed
clinically. These deformities included hammer/claw toes, pes cavus,
prominent metatarsal heads, limited joint mobility at the ﬁrst
metatarsal-phalangeal joint, and hallux valgus. Subjects had to be
able towalk unaided for a distance of at least 100 m. Patientswith non-
diabetic causes of neurological deﬁcit or lower extremity amputation
were excluded. Written informed consent was obtained prior to the
start of the study. All procedures were approved by the medical ethics
committee of the University of Amsterdam Medical Centre.
2.2. Instrumentation
In-shoe dynamic plantar pressure was measured using the Novel
Pedar-X system (Novel GmbH,Munich, Germany). The system comprises
ﬂexible 2 mm thick insoleswith amatrix of 99 capacitance-based sensors
each sampling at 50 Hz,whichwere placed in the shoes between the sock
and insert. Themeasurement insoles are attachedby leads to a data logger
worn by the subject on a waist belt. Data was transmitted through a
wireless Bluetooth connection to a laptop computer on which the data
was stored. In-shoe plantar pressure was measured within a range from
20 to 600 kPa. Six different pairs of wide pedar insoles were available to
accommodate each foot size. Before data collection, each pair of insoles
was calibrated according to the manufacturer's speciﬁcations.
2.3. Footwear
Patients wore newly-prescribed therapeutic footwear, which in-
cluded fully customized footwear (orthopedic footwear), or custom
molded inserts worn in extra-depth shoes (semi-orthopedic footwear).
2.4. Procedures
Before pressure assessment, a ‘zero-calibration’ was performed by
unloading each measurement insole while the patient wore shoes. In-
shoe plantar pressure was assessed while walking in multiple trials
along a 12 m walkway in a laboratory setting. Prior to the collection of
data, subjects performed 2 practice walking trials. Subjects walked at a
self-selected comfortable speed, which was controlled during subse-
quent trials (±5% variation allowed). Walking speed was measured
using a photocell system. It was assured that in-shoe pressures from a
minimum of 20 midgait steps per foot were collected.
2.5. Data analysis
Software from Novel was used to analyze the in-shoe pressure
data. The ﬁrst and last footstep of each walking trial was removed
automatically by the software to avoid acceleration and deceleration
effects on the data. Additionally, footsteps showing sensor errors or
major deviances in the ground reaction force curves were removed
manually. Masks were used to divide the foot into 6 anatomicalregions per foot: heel, midfoot, 1st metatarsal, 2nd to 5th (lesser)
metatarsals, hallux and 2nd to 5th (lesser) toes (Bus et al. 2009). For
each incremental number of footsteps and for each foot region, mean
values for the 30 subjects for peak pressure, pressure–time integral,
contact area, contact time, and force–time integral were calculated.
These 5 parameters were chosen because they are the most
commonly reported parameters in pressure studies on diabetic
footwear. Peak pressure and pressure–time integral are clinically
most relevant, whereas force–time integral is biomechanically
relevant in showing the mechanism of action in load (re-)distribution
of footwear interventions (Bus et al. 2004). The ﬁrst 20 clean midgait
steps per foot were selected for data analysis. The condition with 20
footsteps was used as reference step protocol for statistical analysis.
Each conditionwith an incremental number of footsteps, startingwith
2 and ﬁnishing with 19, was deﬁned as n-step protocol. The left and
right feet were assessed separately.
2.6. Statistical analysis
Statistical analysis was carried out using SPSS statistical software
(Version 18.0). To determine the number of footsteps required for
reliable in-shoe pressure data, Intraclass Correlation Coefﬁcients (ICC)
were calculated per pressure parameter and foot region, for two steps
and for each incremental step up to amaximumof 20 steps. An ICCN0.90
wasconsidered indicativeof excellent reliability (Landis andKoch1977).
Todetermine thenumberof footsteps required for valid in-shoepressure
data, Limits of Agreement analysis was performed in order to take into
account inter-individual differences in gait variability and pressure
recordings (Altman 1991). First, for each pressure parameter and foot
region,mean differences between values of eachn-step protocol and the
reference step protocol were calculated per subject. Ninety-ﬁve percent
limits of agreement of these mean differences were then calculated
per n-step protocol (Formula 1). Subsequently, a coefﬁcient of variation
was calculated between the 95% limits of agreement interval and the
mean value for the 20-step reference protocol (Formula 2). Data was
considered validwhen this coefﬁcient of variationwas b10%. Overall, in-
shoeplantarpressure datawas consideredvalid and reliable in this study
when for all 5 pressure parameters and for all foot regions the criteria for
valid and reliable data were reached.


















Formula 1 and 2: LoA = limits of agreement; CoV = coefﬁcient of
variation; n = number of incremental footsteps in the calculation; μ=
mean value per n footsteps; σ= standard deviation per n footsteps.
The presence of a step or trial effect in the data (values increasing
or decreasing with an incremental number of footsteps) was tested
for each foot region and for each parameter. For this purpose, the
average values of the 30 subjects for each incremental number of
footsteps were plotted. From these plots, linear regression coefﬁcients
were calculated and tested for statistical signiﬁcance (Pb0.05).
Additionally, ANOVA repeated measures and post-hoc analyses were
used to compare the averaged values between each of four blocks of
ﬁve subsequent footsteps (Pb0.05).
3. Results
Between 2 and 5 walking trials on the 12 mwalkwaywere required
to obtain a minimum number of 20 left and right midgait footsteps in
each subject. Six footsteps of 6 different patients showing sensor errors
Table 1
















Heel 213 (75) 73.8 (31.4) 42.2 (5.7) 652 (116) 173.3 (74.3)
Midfoot 143 (74) 65.7 (26.8) 53.0 (9.4) 720 (70) 137.5 (63.0)
Metatarsal 1 237 (102) 69.2 (29.3) 17.9 (3.0) 641 (109) 61.3 (30.5)
Metatarsals 2–5 220 (82) 70.4 (22.4) 40.3 (5.4) 690 (81) 137.7 (52.5)
Hallux 188 (84) 44.6 (7.10) 11.3 (2.6) 541 (77) 26.4 (16.5)
Toes 2–5 207 (86) 55.2 (19.8) 19.2 (7.1) 652 (84) 32.8 (16.9)
Right foot
Heel 210 (77) 68.5 (21.4) 42.1 (5.8) 653 (80) 172.0 (55.3)
Midfoot 140 (65) 64.2 (29.2) 54.3 (9.2) 710 (63) 133.8 (67.4)
Metatarsal 1 220 (70) 64.0 (23.0) 17.2 (2.7) 627 (88) 58.4 (24.1)
Metatarsals 2–5 199 (60) 65.8 (24.6) 40.8 (6.3) 681 (9) 138.9 (75.5)
Hallux 177 (69) 39.0 (17.5) 10.3 (2.2) 518 (41) 21.8 (11.8)
Toes 2–5 172 (79) 47.5 (19.2) 19.3 (4.6) 624 (97) 27.7 (13.8)
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walking speed of the subjects was 1.1(0.2)m/s. Mean values and
standard deviations for each parameter per foot region based on the 20-
step reference protocol are shown in Table 1. In the analysis of a step or
trial effect, none of the regression coefﬁcients was statistically
signiﬁcant. Additionally, no signiﬁcant differences were found between
the average values for the 4 blocks of 5 footsteps, with the exception of
contact time measured in the lesser metatarsal region. This means that
there was no step or trial effect present in the data.
Three steps per foot were required to obtain excellent reliability
scores (ICCN0.90) in all foot region for all pressureparameters (Table 2).
For assessment of data validity, the coefﬁcients of variation gradually
decreased when adding more footsteps to the calculation (Fig. 1). The
number of footsteps required to reach coefﬁcients of variation below
10% per foot region and parameter is shown in Table 3. For peak
pressure, pressure–time integral, contact area, contact time, and force–
time integral, the required number of steps per foot for all foot regions
together was 12, 11, 9, 7, and 17, respectively. More footsteps were
generally required in the right foot compared to the left foot and in the
forefoot compared to the rearfoot.
In the right forefoot, a deviant number of 15, 16, and 17 footsteps
were required to obtain valid force–time integral data in the lesser toes,
hallux, and 1st metatarsal regions, respectively. The data for these foot
regions showed outliers in 3 out of 30 patients. No speciﬁc diseaseTable 2
Intraclass correlation coefﬁcients per foot region for each pressure parameter shown for th
Left foot
Heel Midfoot Metatarsal 1 Metatarsals 2–5 Hallux Toe
Peak pressure
2-step protocol 0.98 0.98 0.97 0.98 0.97 0
3-step protocol 0.99 0.98 0.98 0.99 0.98 0
Pressure–time integral
2-step protocol 0.97 0.97 0.95 0.95 0.96 0
3-step protocol 0.98 0.97 0.96 0.97 0.97 0
Contact area
2-step protocol 0.99 0.98 0.95 0.99 0.99 0
3-step protocol 1.00 0.98 0.96 0.99 0.99 0
Contact time
2-step protocol 0.96 0.97 0.98 0.98 0.88 0
3-step protocol 0.98 0.97 0.99 0.98 0.95 0
Force–time integral
2-step protocol 0.95 0.98 0.93 0.96 0.97 0
3-step protocol 0.97 0.99 0.95 0.98 0.98 0characteristics were present in these patients that may explain these
deviant outcomes. The decline of the coefﬁcients of variation in these
regions with increasing number of footsteps reached a plateau between
10 and 16 footsteps for force–time integral that was more signiﬁcant
than for the other parameters (Fig. 1E). As a result,minor changes in the
coefﬁcient of variation may give larger changes in the number of
required footsteps, which may explain the higher number of footsteps
required for force–time integral in these three regions.
With the exception of force–time integral values in these 3 forefoot
regions of the right foot, 12 steps per foot were required to obtain
valid and reliable data for all pressure parameters in all regions of both
feet.4. Discussion
The aim of this study was to determine the required number of
footsteps for valid and reliable in-shoe plantar pressure data in
neuropathic diabetic patients wearing custom-made therapeutic foot-
wear. For this analysis, we chose to select the 5 most commonly
reported parameters in diabetic footwear studies. The results showed
that only 3 steps per foot were required in these patients to obtain
highly reliable data. To obtain valid in-shoe pressure data, between 7
and 17 steps per foot were required, depending on the parameter of
interest. With the exception of some deviant outcomes for force–time
integral, this study showed that 12 steps per foot were required to
obtain both valid and reliable in-shoe pressure data in all parameters.
Based on these results,we recommend that 12midgait steps per foot are
collected when in-shoe plantar pressure measurements are performed
to evaluate custom-made therapeutic footwear in neuropathic diabetic
patients who are at risk for ulceration.
Within only 3 steps per foot, ICCs reached levels above 0.90 indicating
excellent reliability of the in-shoe plantar pressure data. This is not
surprising considering the consistency that people tend to show from
step-to-step in level walking, resulting in only small differences in
pressure and time parameters between subsequent steps. However, ICC
calculations have the disadvantage that they are inﬂuenced by inter-
subject variability,whichwas large in this studyas the standarddeviations
of the mean outcomes show (Table 1). Furthermore, ICC scores provide
information at group level, not at the individual patient level.Weaimed to
provide recommendations on the use of in-shoe plantar pressure analysis
in individual patients, as this seems more relevant for clinical practice.
Therefore, Limits of Agreement analyses analysis were applied. This
analysis showed that for contact time and contact area fewer footstepse 2-step and 3-step protocols.
Right foot
s 2–5 Heel Midfoot Metatarsal 1 Metatarsals 2–5 Hallux Toes 2–5
.99 0.98 0.95 0.93 0.98 0.95 0.97
.98 0.98 0.96 0.96 0.99 0.96 0.98
.96 0.95 0.97 0.89 0.98 0.93 0.97
.97 0.97 0.97 0.94 0.98 0.95 0.98
.98 0.99 0.98 0.96 0.98 0.99 0.98
.98 0.99 0.98 0.98 0.99 0.97 0.98
.95 0.95 0.96 0.88 0.97 0.94 0.94
.97 0.96 0.97 0.92 0.97 0.94 0.95
.95 0.92 0.98 0.90 0.97 0.97 0.93
.97 0.96 0.99 0.94 0.98 0.98 0.96
Fig. 1. Coefﬁcients of variation shown as a function of the number of footsteps. Data are presented as an average (± 2 SDs) of all 12 foot regions. Curves are shown for (A) peak pressure,
(B) pressure–time integral, (C) contact area, (D) contact time, and (E) force–time integral. The dotted vertical lines deﬁne the number of steps where the coefﬁcients of variation were
smaller than 0.10 (10%) in all 12 regions.
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because they are not inﬂuenced by individual sensor values, giving more
consistent step-to-step outcomes. The lower coefﬁcients of variation for
theseparameters shown in Table 1 also indicate this. Nevertheless, among
the selected parameters, peak pressure is the most commonly reported
and clinically most relevant parameter in assessment of the diabetic foot.
Therefore, the results for peak pressure were leading in the recommen-
dations made.
This priority given in the interpretation to peak pressure was also
one of the reasons to exclude the deviant results on force–time integral
in three right forefoot regions in the recommendations made. Another
reasonwas that the coefﬁcient of variation for force–time integral across
the range of 10–16 footsteps only showed a minimal change (Fig. 1E),
suggesting that the coefﬁcients at 12 footsteps were quite similar to
those of the other pressure parameters. This indicates that the deviant
results on force–time integral had no signiﬁcant impact on the overall
study ﬁndings. Probably for the same reason, differences were found in
the required numbers of steps between the left and right feet (Table 3).
Although these differences were sometimes large, for example for
contact area in the hallux region (2 footsteps required for the left foot, 9
for the right foot), the coefﬁcients of variations at these step numbersTable 3
Number of steps required to obtain coefﬁcients of variation b10% per foot region and parame
Left foot
Heel Midfoot Metatarsal 1 Metatarsals 2–5 Hallux
Peak pressure 8 10 9 7 10
Pressure–time integral 8 9 9 7 8
Contact area 2 2 2 2 2
Contact time 7 2 3 2 6
Force–time integral 10 8 11 7 9were not very different between left and right. Moreover, left–right
differences for the primary parameter, peak pressure, were small.
Therefore, no speciﬁc conclusion should be drawn from the discrepan-
cies between the left and right foot.
The results indicate that more footsteps are required to obtain
reliable and valid in-shoe plantar pressure data in neuropathic
diabetic patients than to obtain reliable data in healthy subjects (8
steps per foot) (Kernozek et al. 1996). However, the current study
showed reliable data after only 3 steps per foot, but valid data after 12
steps per foot. Kernozek et al. did not report on an individual patient-
based validity analysis. Furthermore, data collection methods were
different between studies: treadmill walking at a controlled speed
versus overground walking at a comfortable speed. Finally, neuro-
pathic patients are generally different from healthy subjects in
presence of foot deformity, gait and balance abnormalities, and
footwear use, whichmay also affect in-shoe pressure data consistency
in a different way (Ducic et al. 2004; Katoulis et al. 1997). Therefore, a
valid comparison between these 2 studies is not possible.
Most gait laboratories are conﬁned in space. Therefore, data from
multiple walking trials are often collected to obtain a representative
number of steps per foot for data analysis. In this case, speed ofter. Underlined numbers represent the highest number of required steps per parameter.
Right foot
Toes 2–5 Heel Midfoot Metatarsal 1 Metatarsals 2–5 Hallux Toes 2–5
8 6 11 8 9 9 12
7 6 10 10 7 9 11
5 2 2 2 4 9 8
5 5 2 6 2 7 2
10 9 8 17 6 16 15
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be excluded because speed is outside the set range. Furthermore, data
from multiple walking trials needs further processing to obtain an
ensemble average for all footsteps. Efﬁciency of data collection and
analysis would improve if only 1 walking trial containing 12 steps per
foot would be collected. This would require a setting for unobtrusive
walking along a straight path of about 25 m, and a mobile and
telemetric system that can measure over such a distance. Because a
step or trial effect was not shown in this study, such an effect also
seems unlikely in a longer walking trial of 25 m.
A few limitations apply to this study. First, the criterion level of 10%
for the calculated coefﬁcient of variation and the use of 20 footsteps
as reference protocol were arbitrarily chosen. Different choices may
have resulted in different outcomes. However, as Fig. 1 shows for
the pressure parameters, the decline in coefﬁcient of variation curves
reached some kind of plateau at a level of approximately 10% between
10 and 15 footsteps. Therefore, in hindsight, the 10% criterion level
and the 20-step reference protocol seem to be adequately chosen.
Secondly, an age-matched healthy control group was not included
which limits the assessment of the speciﬁc effect of diabetic
neuropathy on data reliability and validity. Such an assessment was,
however, beyond the scope of this study, in whichwe primarily aimed
to establish recommendations for testing individual neuropathic
diabetic patients in a clinical setting. Further research is needed to
compare patients with healthy subjects.
Finally, the outcomes are speciﬁc for high-risk diabetic patients
being tested in custom-made footwear. Although the data may be
externally valid for other subgroups of patients (e.g. non-neuropathic,
wearing standard footwear, or with active ulceration ofﬂoaded
unilaterally), this cannot be determined from the current study.
Nevertheless, in-shoe plantar pressure analysis seems most relevant
for evaluating therapeutic footwear inhigh-riskneuropathic patients for
preventative purposes.
5. Conclusion
This study showed that 12 midgait steps per foot were required to
obtain reliable and valid in-shoe dynamic plantar pressure data in
neuropathic diabetic patients wearing custom-made therapeutic
footwear. This ﬁnding provides directions for the use of in-shoe
plantar pressure assessment for clinical practice and research
purposes. Furthermore, the results contribute to the standardization
of protocols on foot pressure measurements, a topic that has gained
recent interest within the International Foot and Ankle Biomechanics
community (www.i-fab.org).
Based on the study ﬁndings, we recommend that 12 midgait
steps per foot are collected when dynamic in-shoe plantar pressures
are measured in neuropathic diabetic patients wearing custom-madetherapeutic footwear. If space and equipment allows, data is
preferably collected within one walking trial to improve efﬁciency.
There may be reasons to collect more than 12 steps per foot, for
example to improve statistical power. However, we suggest that this
is considered in relation to need, possible patient burden, and
efﬁciency. We further recommend that authors report the (minimal)
number of footsteps collected for in-shoe plantar pressure analysis.
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